Ardelyx, Inc. - Common Stock (NQ:ARDX)

Unlock robust upside potential by wagering on these top penny stocks to buy in a volatile market at this time.

7 Penny Stocks You’ll Regret Not Buying Soon: November 2023

November 21, 2023

Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia

November 15, 2023

Ardelyx delivered a strong quarter thanks to solid demand for its first FDA-approved product. Here's what investors need to know.

Why Ardelyx Stock Soared Today

October 31, 2023

Via The Motley Fool

Ardelyx Announces Departure of Board Member

November 13, 2023

Ardelyx to Participate at the Jefferies London Healthcare Conference

November 10, 2023

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

5 OTC Stocks With The Potential To Explode In 2024

November 08, 2023

Via Benzinga

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States

November 06, 2023

The company's hopes for approval of a drug to treat chronic kidney disease took a hit.

Why Shares of Ardelyx Were Down Wednesday

October 11, 2023

Via The Motley Fool

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

November 03, 2023

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance

October 31, 2023

Ardelyx, Inc. Reports Employment Inducement Grants

October 30, 2023

These three penny stocks are the ones to buy and hold through the market conditions and the years to come for returns.

3 Penny Stocks to Buy and Hold for the Next 10 Years

October 29, 2023

Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023

October 23, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

October 19, 2023

Via Benzinga

Why Ardelyx Stock Popped Today

October 18, 2023

Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug.

Via The Motley Fool

Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023

October 18, 2023

Conference call scheduled for 8:00 a.m. Eastern Time

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling more than 1% on Wednesday. The Dow traded down 0.70% to 33,760.26 while the NASDAQ fell 1.45% to 13,338.71. The S&P 500 also...

Crude Oil Rises Sharply; Ardelyx Shares Spike Higher

October 18, 2023

Via Benzinga

Topics Stocks

Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

October 18, 2023

Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.

Via Benzinga

Topics Bankruptcy

Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday

October 18, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Ardelyx Inc. (NASDAQ: ARDX) is One of Wednesday Morning’s Most Active Stocks

October 18, 2023

Via Investor Brand Network

Workhorse (WKHS) Stock Jumps on Drone Business Success

October 18, 2023

Workhorse stock is getting a boost on Wednesday morning after providing WKHS investors with an update on its drone business.

ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment.

FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug

October 18, 2023

The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on...

After Initial Rejection, FDA Approves Ardelyx's Kidney Disease-Related Drug

October 18, 2023

Via Benzinga

Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital

October 17, 2023

Additional non-dilutive capital extends runway to support the launch of XPHOZAH® (tenapanor) and continued commercial investment into IBSRELA® (tenapanor) in the U.S.

FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor

October 17, 2023

It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

October 17, 2023

Ardelyx to Present Data Updates for XPHOZAH (tenapanor) for Hyperphosphatemia at Kidney Week 2023 November 1-5 in Philadelphia, PA

October 13, 2023